BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22236862)

  • 1. Ethionamide-induced hypothyroidism.
    Dutta BS; Hassan G; Waseem Q; Saheer S; Singh A
    Int J Tuberc Lung Dis; 2012 Jan; 16(1):141. PubMed ID: 22236862
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypothyroidism due to ethionamide.
    McDonnell ME; Braverman LE; Bernardo J
    N Engl J Med; 2005 Jun; 352(26):2757-9. PubMed ID: 15987931
    [No Abstract]   [Full Text] [Related]  

  • 3. Abnormal thyroid function tests in children on ethionamide treatment.
    Thee S; Zöllner EW; Willemse M; Hesseling AC; Magdorf K; Schaaf HS
    Int J Tuberc Lung Dis; 2011 Sep; 15(9):1191-3, i. PubMed ID: 21943844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Two cases of multi-drug-resistant pulmonary tuberculosis with para-aminosalicylic acid (PAS)-induced hypothyroidism].
    Mizutani H; Horiba M; Shindoh J; Kimura T; Son M; Wakahara K
    Kekkaku; 2001 Oct; 76(10):667-72. PubMed ID: 11712388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profile of adverse drug reactions in drug resistant tuberculosis from Punjab.
    Bhushan B; Chander R; Kajal NC; Ranga V; Gupta A; Bharti H
    Indian J Tuberc; 2014 Oct; 61(4):318-24. PubMed ID: 25675695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gynecomastia in multi-drug resistant tuberculosis - ethionamide the villain.
    Deokar K; Shaikh AL; Chawla G
    Adv Respir Med; 2020; 88(2):162-163. PubMed ID: 32383471
    [No Abstract]   [Full Text] [Related]  

  • 7. Ethionamide induced blue vision (cyanopsia): Case report.
    Jain AK; Sharma P
    Indian J Tuberc; 2020 Jul; 67(3):333-335. PubMed ID: 32825860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothyroidism related to ethionamide.
    Moulding T; Fraser R
    Am Rev Respir Dis; 1970 Jan; 101(1):90-4. PubMed ID: 5410078
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug-induced hypothyroidism in patients receiving treatment for multidrug-resistant tuberculosis in the UK.
    Gupta J; Breen RA; Milburn HJ
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1278. PubMed ID: 22871328
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro physicochemical characterization and short term in vivo tolerability study of ethionamide loaded PLGA nanoparticles: potentially effective agent for multidrug resistant tuberculosis.
    Kumar G; Malhotra S; Shafiq N; Pandhi P; Khuller GK; Sharma S
    J Microencapsul; 2011; 28(8):717-28. PubMed ID: 21985449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothyroidism in a patient receiving treatment for multidrug-resistant tuberculosis.
    Soumakis SA; Berg D; Harris HW
    Clin Infect Dis; 1998 Oct; 27(4):910-1. PubMed ID: 9798062
    [No Abstract]   [Full Text] [Related]  

  • 12. Gynecomastia caused by ethionamide.
    Sharma PK; Bansal R
    Indian J Pharmacol; 2012; 44(5):654-5. PubMed ID: 23112434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment and follow-up of HIV-negative multidrug-resistant tuberculosis patients in an infectious diseases reference hospital, Buenos Aires, Argentina.
    Palmero DJ; Ambroggi M; Brea A; De Lucas M; Fulgenzi A; Martínez D; Mosca C; Musella R; Natiello M; Gonzalez C; Abbate E
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):778-84. PubMed ID: 15182150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [2 cases of agranulocytosis during therapy with ethionamide and ethoxyd in patients with pulmonary tuberculosis].
    Kurenkova VV
    Probl Tuberk; 1967; 45(4):82-3. PubMed ID: 5605430
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
    Prasad R; Verma SK; Sahai S; Kumar S; Jain A
    Indian J Chest Dis Allied Sci; 2006; 48(3):183-6. PubMed ID: 18610675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug resistance pattern in multidrug resistance pulmonary tuberculosis patients.
    Rao NA; Irfan M; Soomro MM; Mehfooz Z
    J Coll Physicians Surg Pak; 2010 Apr; 20(4):262-5. PubMed ID: 20392404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of the adverse effects of prothionamide and ethionamide in the treatment of pulmonary tuberculosis].
    Rózewska M
    Gruzlica; 1969 Dec; 37(12):1103-6. PubMed ID: 5368636
    [No Abstract]   [Full Text] [Related]  

  • 18. A patient of multidrug-resistant tuberculosis on category IV treatment regimen presenting with psychosis.
    Sarkar S; Sood M
    Natl Med J India; 2011; 24(4):244-5. PubMed ID: 22208150
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevalence of hypothyroidism among MDR-TB patients in Botswana.
    Modongo C; Zetola NM
    Int J Tuberc Lung Dis; 2012 Nov; 16(11):1561-2. PubMed ID: 23044454
    [No Abstract]   [Full Text] [Related]  

  • 20. Radiometric vs. agar proportion methods for assessing ethionamide resistance and its clinical effects in multidrug-resistant tuberculosis.
    Cimen NO; Arslan Z; Saygi A; Ocak K; Babacan F; Kurutepe M
    Int J Tuberc Lung Dis; 2009 Jul; 13(7):907-13. PubMed ID: 19555543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.